STAGE Evaluation of therapeutic peptides

Date de mise à jour de l’offre

PEP-Therapy :

PEP-Therapy is a medical biotechnology company which develops targeted therapies for the treatment of severe diseases having high medical needs, with an initial focus on cancers. PEP-Therapy operates a Cell Penetrating and Interfering Peptides (CP&IP) technology for the development of its therapeutic products. These innovative molecules penetrate cells then specifically block relevant intracellular protein/protein interactions, thus inhibiting key pathological mechanisms. PEP-Therapy has been incorporated in 2014. The company is building on research results from Inserm, Institut Curie and Sorbonne University. For further information:

Description de la mission

Study of the mechanism of action of cell penetrating peptides
Validation of biomarkers

Profil recherché

4 to 5-year-university degree or master equivalent;
Area of expertise: microbiology, analytical biology, biotechnologies;
Experience in a R&D lab environment, preferably in industry.
Technical skills:
Cell culture, microscopy, FACS;
Molecular Biology (RT-qPCR)
Ability to follow protocols and analyze data;
Basic working knowledge of Microsoft Word, Excel, Power Point;
Command of spoken English.

Niveau de qualification requis

Bac + 4/5 et +
  • Employeur
  • Secteur d’activité de la structure
    Enseignement - Formation - Recherche
  • Effectif de la structure
    De 0 à 10 salariés
  • Type de stage ou contrat
    Stage pour lycéens et étudiants en formation initiale
  • Date prévisionnelle de démarrage
  • Durée du stage ou contrat
    Plus de 4 mois et jusqu'à 6 mois
  • Le stage est-il rémunéré ?
  • Niveau de qualification requis

    Bac + 4/5 et +
  • Lieu du stage
    Hôpital La Pitié Salpêtrière (75013) + bureaux de PEP-Therapy (75005)
  • Accès et transports